Settings Order Article Reprints Open AccessReview Selenium And Chronic Diseases A Nutritional Genomics Perspective

Selenium is an essential mineral that plays important roles in protecting cells from damage, supporting proper protein function, and maintaining cellular health. While studies have shown that people with low selenium intake have higher risks of developing chronic diseases like cancer, clinical trials testing selenium supplements have produced inconsistent and sometimes confusing results. This research review examines why these conflicting outcomes occur by looking at the intersection of genetics and nutrition.

The key finding is that genetic variations - specifically single nucleotide polymorphisms (SNPs) - significantly influence how your body processes and uses selenium. These genetic differences affect how selenium is metabolized, how selenoproteins (selenium-containing proteins) are made, and how effectively they function in your body. The research shows that your individual genetic makeup determines whether selenium supplementation will be beneficial, neutral, or potentially harmful for preventing chronic diseases.

This personalized response to selenium helps explain why population-wide studies have been disappointing - what works for one person may not work for another based on their genetic profile. The research identified complex interactions between multiple genetic variants, selenium status in the body, and environmental factors that together influence disease risk, particularly for cancer.

For patients interested in metabolic health and longevity, this research highlights the importance of personalized nutrition approaches. Rather than assuming all supplements work the same for everyone, understanding your genetic predisposition to selenium metabolism could inform more targeted and effective supplementation strategies as part of comprehensive metabolic health optimization.